Best Alzheimer's and Dementia Research Grants in Georgia

ISTAART Professional Interest Area executive committee members worldwide can request up to US $20,000 to organize dementia and Alzheimer’s research conferences, workshops, or convenings through this program. Georgia-based dementia researchers engaged in ISTAART PIAs may be eligible to support training, networking, and knowledge-sharing events that advance the field.

The McKnight Brain Research Foundation Innovator Awards aim to support innovative research in cognitive aging and memory loss, offering two 3-year grants of $750,000 each. Targeted at early-career investigators, the program encourages high-risk, high-gain proposals that explore clinical translational research and the biological mechanisms of cognitive aging. By fostering emerging scientific leaders, the initiative seeks to advance transformative discoveries in this critical area of aging research, enhancing understanding and treatment of age-related cognitive decline.

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

Georgia nonprofit member organizations of the Alzheimer’s Foundation of America that run programs for people affected by Alzheimer’s or related dementias can access this bi-annual grant. Funding of US $6,000 can support new or existing services, including administrative costs, staff salaries and training, occupancy, and necessary supplies or equipment.

Universities, research institutions, and medical centers in Georgia working on Alzheimer’s and related dementias can access funding through the National Institutes of Health to run postbaccalaureate research education programs, with awards up to US $400,000. These one-to-two-year programs provide intensive AD/ADRD research experience, mentorship, and professional development for recent graduates across U.S. states and territories.

Nonprofit and academic organizations offering Alzheimer’s and dementia-focused summer research education in Georgia can apply for up to US $200,000 to run hands-on programs for high school students, undergraduates, or science teachers. With a mission to advance dementia and STEM research, the National Institutes of Health supports authentic lab experiences and complementary educational enrichment activities.

Georgia dementia and Alzheimer’s disease researchers can access funding through the Alzheimer’s Association AARGA program, which supports early-career investigators developing pilot or preliminary data. U.S. and international assistant professors (or equivalent, within seven years) may receive US $70,000 - US $200,000 for basic, translational, clinical, psychosocial, or related dementia research projects.

Georgia nonprofits with 501(c)(3) status working on dementia and brain degenerative disease care can access funding through Sephardic Home For The Aged Foundation to improve support and quality of life for older adults. Eligible organizations must be at least two years old and may propose innovative aging-related programs or services.

Postdoctoral researchers conducting Alzheimer’s and dementia research in Georgia can seek funding for early-career projects through the Alzheimer’s Association Research Fellowship for All, with awards up to US $200,000. Grants from the Alzheimer’s Association support mentored research that helps investigators transition toward independent careers in Alzheimer’s and related dementias, encouraging applicants from underrepresented groups.

Clinician scientists conducting dementia and Alzheimer’s disease research in Georgia can access funding through the Alzheimer’s Association, with awards up to US $250,000. Licensed, practicing clinicians in patient-facing or diagnostic fields may be eligible, and individuals from underrepresented groups are especially encouraged to apply for this fellowship support.

With a mission to support individuals and families affected by dementia, Alzheimer’s Foundation of America provides Georgia Alzheimer’s-focused nonprofits with US $25,000 for innovative programs improving quality of life. Only AFA nonprofit member organizations may apply, and funds can cover program-related staff, training, occupancy, supplies, equipment, and other eligible administrative costs.

Public safety agencies in Georgia that belong to both the Alzheimer’s Foundation of America and Project Lifesaver International can seek funding for dementia-related wandering prevention and public safety initiatives. Focused on dementia and Alzheimer’s disease, the Alzheimer’s Foundation of America invites eligible agencies to apply for US $6,000 to support training, equipment, administration, and community outreach.

Nonprofit organizations providing Alzheimer’s respite care services in Georgia can apply for Alzheimer’s Foundation of America’s Milton & Phyllis Berg Family Respite Care Grants; awards US $6,000 for respite care scholarships and related program costs. Funding may cover supplies, equipment, capacity building, administrative expenses, and staff training to better support dementia-affected families.

Georgia research institutions and medical centers conducting imaging research on Alzheimer’s and other neurodegenerative diseases can access funding through the Alzheimer’s Association and the American Society of Neuroradiology. Grants from Alzheimer’s Association help Georgia dementia and Alzheimer’s disease researchers pursue early-stage pilot projects, novel imaging tools, and innovative imaging data analysis, with awards of US $200,000.

Families needing in-home respite care for loved ones with Alzheimer’s or other dementias in the Boyertown Area School District can apply for the Margaret B. Moeller Memorial Fund, awarding US $200 - US $3,000 for companion or aide services. Georgia organizations serving such families may note this as a model but are not the direct applicants.

Research institutions and qualified organizations studying Alzheimer’s and dementia can apply for National Institutes of Health phased grants supporting functional validation of new therapeutic targets, including work in Georgia. Funding supports technology development, disease models, and cross-lab validation to de-risk translational research, though applications are not being accepted yet as this is an advance notice.

Research institutions and eligible organizations in Georgia studying dementia and Alzheimer’s care pathways and early detection can apply for the Alzheimer’s Association’s Health Services Research in Alzheimer’s Disease and Related Disorders program, with awards up to US $250,000. Funding supports rigorous health services research on detection, diagnosis, and post-diagnostic care for cognitive impairment, including MCI and AD/ADRD.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.

The National Institute on Aging (NIA) is inviting applications for the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional). This initiative seeks to support pre-clinical and early-stage clinical development of innovative drug candidates aimed at preventing Alzheimer's disease or treating its symptoms. The program encourages collaboration among researchers and aims to enhance the therapeutic pipeline for AD through targeted approaches. This notice allows potential applicants time to prepare robust projects.

The Alzheimer's Disease Programs Initiative (ADPI) aims to foster the development of dementia-capable community health worker programs within the National Aging Network. This initiative, supported by the US HHS: Administration for Community Living (ACL), seeks to enhance dementia screening, reduce barriers to care, and improve access to essential services for individuals with dementia and their caregivers. By integrating community health workers into aging services, the program aspires to elevate the quality of life for those affected.

BrightFocus Foundation offers Alzheimer's Disease Research Grants to support innovative research aimed at understanding, preventing, and treating Alzheimer's disease. These grants encourage applications from diverse backgrounds, fostering creativity in scientific research. The program includes Standard Awards for early investigators with a maximum funding of $300,000 for three years and Postdoctoral Fellowship Awards for young researchers at $200,000 for two years, promoting the development of independent research careers.

The Barney Family Foundation Grant focuses on improving early education and advancing medical research, particularly in cancer and Alzheimer’s. It supports organizations that demonstrate a clear plan to enhance children's life experiences and educational opportunities for those in grades K-8. Grants typically range from $5,000 to $50,000, prioritizing established entities while welcoming startups. Eligible applicants must have 501(c)(3) status, and the Foundation does not fund individual requests or political activities.

The ADDF-Harrington Scholar Program aims to transform academic discoveries into effective treatments for Alzheimer’s disease and related dementias. With funding of up to $600,000 annually, this program prioritizes innovative drug targets and supports research from hit-to-lead optimization to IND-enabling studies. Eligible applicants include academic investigators with a strong potential to advance meaningful therapeutics. The program emphasizes collaboration with industry experts, making it a significant opportunity for advancing dementia research.

The CART Fund Grant supports innovative Alzheimer’s Disease research projects in the U.S. with funding up to $500,000 for a two-year period. It invites full-time faculty from public and private institutions to submit Letters of Intent, emphasizing novel concepts that advance biomedical knowledge. Selected finalists will be invited to apply for standard grants. The initiative aims to foster groundbreaking research initiatives lacking extensive preliminary data, ensuring a focus on projects with transformative potential.